Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 6/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 4/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.44 |
| ▸ | CA2 | P00918 | 3/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | MMP9 | P14780 | 1/20 | 0.36 |
| ▸ | MMP8 | P22894 | 1/20 | 0.36 |
| ▸ | MMP14 | P50281 | 1/20 | 0.36 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.36 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6909734 | 0.85 | CYP3A4 (0.61) | CYP3A4L3MBTL1TSHRTDP1ATM | |
| SCHEMBL12038324 | 0.85 | CYP3A4 (0.61) | CYP3A4L3MBTL1TSHRTDP1ATM | |
| SCHEMBL599571 | 0.85 | CYP3A4 (0.61) | CYP3A4L3MBTL1TSHRTDP1ATM | |
| SCHEMBL9497372 | 0.84 | CYP3A4 (0.59) | CYP3A4L3MBTL1TSHRTDP1ATM | |
| SCHEMBL27358148 | 0.84 | CYP3A4 (0.59) | CYP3A4L3MBTL1TSHRTDP1ATM | |
| SCHEMBL4650272 | 0.84 | CYP3A4 (0.59) | CYP3A4L3MBTL1TSHRTDP1ATM | |
| SCHEMBL4446173 | 0.82 | CYP3A4 (0.58) | CYP3A4L3MBTL1TSHRTDP1ATM | |
| SCHEMBL284454 | 0.81 | CYP3A4 (0.66) | CYP3A4L3MBTL1TSHRTDP1ATM | |
| Water SCHEMBL28800711 | 0.81 | CYP3A4 (0.56) | CYP3A4L3MBTL1TSHRTDP1ATM | |
| SCHEMBL27544223 | 0.81 | CYP3A4 (0.56) | CYP3A4L3MBTL1TSHRTDP1ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8791056-B2 | Alkylphosphorofluoridothioates having low wear volume and methods for synthesizing and using same | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2014-07-29 | — | — | US | disclosed |
| US-20110319303-A1 | ALKYLPHOSPHOROFLUORIDOTHIOATES HAVING LOW WEAR VOLUME AND METHODS FOR SYNTHESIZING AND USING SAME | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2011-12-29 | — | — | US | disclosed |
| WO-2011163592-A2 | ALKYLPHOSHOROFLUORIDOTHIOATES HAVING LOW WEAR VOLUME AND METHODS FOR SYNTHESIZING AND USING SAME | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2011-12-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110319303-A1 | ALKYLPHOSPHOROFLUORIDOTHIOATES HAVING LOW WEAR VOLUME AND METHODS FOR SYNTHESIZING AND USING SAME | ACR, MTAP, PLTP | CYP3A4 3179/4885L3MBTL1 2059/4885TSHR 1627/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.